ZA91381B - Polyanhydrides of oligomerized unsaturated aliphatic acids - Google Patents
Polyanhydrides of oligomerized unsaturated aliphatic acidsInfo
- Publication number
- ZA91381B ZA91381B ZA91381A ZA91381A ZA91381B ZA 91381 B ZA91381 B ZA 91381B ZA 91381 A ZA91381 A ZA 91381A ZA 91381 A ZA91381 A ZA 91381A ZA 91381 B ZA91381 B ZA 91381B
- Authority
- ZA
- South Africa
- Prior art keywords
- polyanhydrides
- unsaturated aliphatic
- aliphatic acids
- oligomerized unsaturated
- oligomerized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G67/00—Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
- C08G67/04—Polyanhydrides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G67/00—Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
- C08G67/02—Copolymers of carbon monoxide and aliphatic unsaturated compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Polyethers (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Moulding By Coating Moulds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/467,635 US5171812A (en) | 1990-01-19 | 1990-01-19 | Polyanhydrides of oligomerized unsaturated aliphatic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA91381B true ZA91381B (en) | 1992-02-26 |
Family
ID=23856493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA91381A ZA91381B (en) | 1990-01-19 | 1991-01-18 | Polyanhydrides of oligomerized unsaturated aliphatic acids |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5171812A (de) |
| EP (1) | EP0511292B1 (de) |
| JP (1) | JP3126141B2 (de) |
| KR (1) | KR920703685A (de) |
| AT (1) | ATE192174T1 (de) |
| AU (1) | AU637883B2 (de) |
| DE (1) | DE69132138T2 (de) |
| IE (1) | IE910100A1 (de) |
| NZ (1) | NZ236807A (de) |
| WO (1) | WO1991010696A1 (de) |
| ZA (1) | ZA91381B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843089A (en) | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
| US5660851A (en) * | 1989-12-26 | 1997-08-26 | Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem | Ocular inserts |
| US5317079A (en) * | 1990-01-19 | 1994-05-31 | Nova Pharmaceutical Corporation | Fatty acid terminated polyanhydride |
| US5175235A (en) * | 1990-06-04 | 1992-12-29 | Nova Pharmaceutical Corporation | Branched polyanhydrides |
| US5197882A (en) * | 1990-05-14 | 1993-03-30 | Gary R. Jernberg | Periodontal barrier and method for aiding periodontal tissue regeneration agents |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5473103A (en) * | 1993-12-16 | 1995-12-05 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Biopolymers derived from hydrolyzable diacid fats |
| US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| US5622166A (en) * | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
| US6303134B1 (en) * | 1996-08-29 | 2001-10-16 | Advanced Research And Technology Institute, Inc. | Pharmacotherapeutic process and composition for central nervous system disorders |
| US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| US6503528B1 (en) | 1999-11-19 | 2003-01-07 | Abbott Laboratories | Polymeric compositions and a method of making the same |
| AU2001257129A1 (en) * | 2000-04-21 | 2001-11-07 | Advanced Research And Technology Institute, Inc. | Novel pharmacotherapeutic process and composition for central nervous system disorders |
| US6506408B1 (en) * | 2000-07-13 | 2003-01-14 | Scimed Life Systems, Inc. | Implantable or insertable therapeutic agent delivery device |
| IL140017A (en) * | 2000-11-30 | 2009-09-22 | Abraham J Domb | Polyhedra |
| US7749539B2 (en) * | 2000-11-30 | 2010-07-06 | Efrat Biopolymers Ltd. | Polymeric formulations for drug delivery |
| US6908622B2 (en) | 2001-09-24 | 2005-06-21 | Boston Scientific Scimed, Inc. | Optimized dosing for drug coated stents |
| US7141648B2 (en) | 2001-10-19 | 2006-11-28 | Isotechnika Inc. | Synthesis of cyclosporin analogs |
| US7306580B2 (en) * | 2003-04-16 | 2007-12-11 | Cook Incorporated | Medical device with therapeutic agents |
| US7662864B2 (en) | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| AU2004267349B2 (en) * | 2003-07-01 | 2011-02-24 | Mayo Foundation For Medical Education And Research | Hydroxyapatite grafted fumarate based macromers for biodegradable composites |
| US8143368B2 (en) * | 2004-12-23 | 2012-03-27 | Massachusetts Institute Of Technology | Disposable medical supplies from hydrolytically biodegradable plastics |
| GB2433122B (en) | 2005-12-10 | 2008-07-23 | Endet Ltd | Gas sampling probe |
| US20070162110A1 (en) * | 2006-01-06 | 2007-07-12 | Vipul Bhupendra Dave | Bioabsorbable drug delivery devices |
| US10023521B2 (en) | 2014-06-13 | 2018-07-17 | Rutgers, The State University Of New Jersey | Process and intermediates for preparing poly(anhydride-esters) |
| AU2015365566B2 (en) | 2014-12-18 | 2020-02-27 | Dexcel Pharma Technologies Ltd. | Alternating and semi-alternating poly(ester-anhydride) copolymers |
| AU2017406466A1 (en) | 2017-03-29 | 2019-10-17 | Dexcel Pharma Technologies Ltd. | Compositions comprising biodegradable copolymers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757128A (en) * | 1986-08-01 | 1988-07-12 | Massachusetts Institute Of Technology | High molecular weight polyanhydride and preparation thereof |
| US4888176A (en) * | 1984-05-21 | 1989-12-19 | Massachusetts Institute Of Technology | Controlled drug delivery high molecular weight polyanhydrides |
| US4891225A (en) * | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
| US4886870A (en) * | 1984-05-21 | 1989-12-12 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| CH671402A5 (de) * | 1985-10-02 | 1989-08-31 | Sandoz Ag | |
| US4789724A (en) * | 1986-10-17 | 1988-12-06 | Massachusetts Institute Of Technology | Preparation of anhydride copolymers |
| US4857311A (en) * | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
| US4916204A (en) * | 1987-07-31 | 1990-04-10 | Massachusetts Institute Of Technology | Pure polyanhydride from dicarboxylic acid and coupling agent |
| US5019379A (en) * | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
-
1990
- 1990-01-19 US US07/467,635 patent/US5171812A/en not_active Expired - Lifetime
-
1991
- 1991-01-07 JP JP03503553A patent/JP3126141B2/ja not_active Expired - Fee Related
- 1991-01-07 WO PCT/US1991/000126 patent/WO1991010696A1/en not_active Ceased
- 1991-01-07 AT AT91903474T patent/ATE192174T1/de not_active IP Right Cessation
- 1991-01-07 AU AU72257/91A patent/AU637883B2/en not_active Ceased
- 1991-01-07 EP EP91903474A patent/EP0511292B1/de not_active Expired - Lifetime
- 1991-01-07 DE DE69132138T patent/DE69132138T2/de not_active Expired - Fee Related
- 1991-01-07 KR KR1019920701687A patent/KR920703685A/ko not_active Abandoned
- 1991-01-11 IE IE010091A patent/IE910100A1/en not_active Application Discontinuation
- 1991-01-17 NZ NZ236807A patent/NZ236807A/en unknown
- 1991-01-18 ZA ZA91381A patent/ZA91381B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05505632A (ja) | 1993-08-19 |
| KR920703685A (ko) | 1992-12-18 |
| IE910100A1 (en) | 1991-07-31 |
| AU637883B2 (en) | 1993-06-10 |
| JP3126141B2 (ja) | 2001-01-22 |
| US5171812A (en) | 1992-12-15 |
| ATE192174T1 (de) | 2000-05-15 |
| WO1991010696A1 (en) | 1991-07-25 |
| NZ236807A (en) | 1992-07-28 |
| DE69132138D1 (de) | 2000-05-31 |
| EP0511292A1 (de) | 1992-11-04 |
| AU7225791A (en) | 1991-08-05 |
| DE69132138T2 (de) | 2000-09-21 |
| EP0511292B1 (de) | 2000-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA91381B (en) | Polyanhydrides of oligomerized unsaturated aliphatic acids | |
| ES2094888T3 (es) | Procedimiento de preparacion de un aposito con matriz. | |
| EP0293852A3 (de) | Organopolysiloxanzusammensetzungen, die funktionelle alpha,beta-ungesättigte Carbonylgruppen enthalten | |
| DE69112156D1 (de) | Gerät zur Realisierung von Datenbanken zum Verschaffen von objektorientiertem Aufrufen von Anwendungsprogrammen. | |
| GB9018144D0 (en) | Polymerisation process | |
| GR3029791T3 (en) | Improved immunogenic compositions against human gastrin 17 | |
| ZA882198B (en) | Branched acrylate copolymer with polisable(sic)double bonds and processes for the preparation of the acrylate copolymer | |
| DK0612753T3 (da) | Organo-aluminoxyprodukt og anvendelse deraf | |
| DE3260410D1 (en) | Plant growth stunting agent | |
| HU913177D0 (en) | Process for the polymerization of ethylenes | |
| GR930300011T1 (en) | Process for producing polyacrylic acids. | |
| MY109366A (en) | Polysuccinimide polymers and process for preparing polysuccinimide polymers | |
| DE69032371D1 (de) | Bilderzeugung nach dem echoplanarverfahren mit 180 grad-pulsen | |
| GB9014724D0 (en) | Process for the preparation of alpha,beta-olefinically unsaturated compounds | |
| MY107279A (en) | Perfluoro-n,n,n'',n''-tetrapropydiaminopropane and use thereof in vapor phase heating. | |
| HUT66234A (en) | Process to prepare 4,13-dioxabicyclo(8.2.1)-tridecenon-derivatives and pharmaceutical compositions containing them | |
| DE2965266D1 (en) | Process for preparing polyamides free from monomers and dimers | |
| PH24245A (en) | 3-(omega-(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles,their de-oxy analogs and therepeutic uses thereof | |
| GB2014141B (en) | 8 -ethyl and 8 -methyl 4,5a-epoxymorphinan -6- one compounds | |
| CA2073561A1 (en) | Polyanhydrides of the oligomerized unsaturated aliphatic acids | |
| EP0457610A3 (en) | Unsaturated group and fluorine containing block copolymers, process for preparing the same and use | |
| FR2610938B1 (fr) | Compositions de polybenzhydrolimides terminees par des groupements a insaturation ethylenique, les polyimides reticules obtenus par leur polymerisation thermique et l'utilisation de ces compositions | |
| IL89331A0 (en) | Preparation of 3,3-diarylacrylic acid amides | |
| EP0317913A3 (en) | Di(meth)acrylates, process for their preparation and their use | |
| IT7824578A0 (it) | Composizione farmaceutica per la terapia di stati di frigidita' ed impotenza. |